AMC: Analysts Call For EPS Of -$0.19 In Q2

AMC Entertainment Holdings, Inc. (NYSE: AMC) will report its second quarter financial results on August 4th after market close. Analysts have a consensus $9.09 12-month price target on the company, via a total of 8 analysts, with 3 analysts having hold ratings, 3 analysts have sell ratings and the last 2 analysts have strong sell ratings on the stock.

Seven analysts have revenue estimates for the second quarter. The mean revenue estimate between all seven analysts is $1.18 billion; this number has been revised downwards from $1.25 billion at the start of the year. The highest revenue estimate is $1.28 billion, while the lowest is $1.1 billion.

Onto EBITDA estimates, there are currently seven analysts who have second quarter EBITDA estimates. The mean is currently $78.9 million, with this number having been revised downwards from $148 million at the start of the year. Street high is a $126.6 million EBITDA estimate and the lowest is $15.9 million.

Analysts estimate that quarterly earnings per share will come in at -$0.19, with this number being revised downwards from -$0.11 at the start of the year. The street high estimate is -$0.09 and the lowest estimate is -$0.36 per share for the quarter.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to the organizations discussed. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Moon River Moly: The Davidson Moly-Copper-Tungsten PEA

Integra: The DeLamar Heap Leach Feasibility Study

Highlander Silver: The Saviour Of Bear Creek Mining

Recommended

Silver47 Begins Drill Program At Mogollan Project In New Mexico Targeting High Grade Silver

Steadright Expects To Receive Mining License For New Copper Valley Project Within The Next Month

Related News

Magna International: BMO Expects The Worst To Be Over

Last week, Magna International (TSX: MG) reported its third quarter financial results. The company reported...

Monday, November 15, 2021, 04:02:00 PM

Mind Medicine: Canaccord Maintains Ratings Following Financial Results

On Friday, November 13th, Mind Medicine (NEO: MMED) reported their third quarter 2020 financial results....

Tuesday, November 17, 2020, 10:17:00 AM

Canaccord Genuity Raises Medipharm Labs’ Price Target To C$2.50

On Monday Medipharm Labs (TSX: LABS) announced an exclusive medical cannabis partnership with the European...

Tuesday, October 6, 2020, 01:29:18 PM

BMO Lowers Revenue Forecast For OceanaGold Following COVID Outbreak

OceanaGold Corp (TSX: OGC) provided a corporate update to their investors on August 27. Included...

Sunday, August 30, 2020, 01:43:00 PM

Canaccord Lowers Aurora Cannabis Price Target To $5 Following Q2 Earnings

On February 10th, Aurora Cannabis (TSX: ACB) reported its fiscal second quarter 2022 results. The...

Sunday, February 13, 2022, 05:16:00 PM